Literature DB >> 17005723

Activation, internalization, and recycling of the serotonin 2A receptor by dopamine.

Samarjit Bhattacharyya1, Ishier Raote, Aditi Bhattacharya, Ricardo Miledi, Mitradas M Panicker.   

Abstract

Serotonergic and dopaminergic systems, and their functional interactions, have been implicated in the pathophysiology of various CNS disorders. Here, we use recombinant serotonin (5-HT) 2A (5-HT2A) receptors to further investigate direct interactions between dopamine and 5-HT receptors. Previous studies in Xenopus oocytes showed that dopamine, although not the cognate ligand for the 5-HT2A receptor, acts as a partial-efficacy agonist. At micromolar concentrations, dopamine also acts as a partial-efficacy agonist on 5-HT2A receptors in HEK293 cells. Like 5-HT, dopamine also induces receptor-internalization in these cells, although at significantly higher concentrations than 5-HT. Interestingly, if the receptors are first sensitized or "primed" by subthreshold concentrations of 5-HT, then dopamine-induced internalization occurs at concentrations approximately 10-fold lower than when dopamine is used alone. Furthermore, unlike 5-HT-mediated internalization, dopamine-mediated receptor internalization, alone, or after sensitization by 5-HT, does not depend on PKC. Dopamine-internalized receptors recycle to the surface at rates similar to those of 5-HT-internalized receptors. Our results suggest a previously uncharacterized role for dopamine in the direct activation and internalization of 5-HT2A receptors that may have clinical relevance to the function of serotonergic systems in anxiety, depression, and schizophrenia and also to the treatment of these disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005723      PMCID: PMC1622808          DOI: 10.1073/pnas.0606578103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Oligomerization of G-protein-coupled transmitter receptors.

Authors:  M Bouvier
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Authors:  M Rocheville; D C Lange; U Kumar; S C Patel; R C Patel; Y C Patel
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

3.  The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro.

Authors:  Z Xia; S J Hufeisen; J A Gray; B L Roth
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

4.  A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases.

Authors:  Deborah M Kurrasch-Orbaugh; Jason C Parrish; Val J Watts; David E Nichols
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

5.  Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.

Authors:  Agnès Auclair; Gérard Blanc; Jacques Glowinski; Jean-Pol Tassin
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

6.  Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area.

Authors:  M D Doherty; V M Pickel
Journal:  Brain Res       Date:  2000-05-12       Impact factor: 3.252

7.  Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.

Authors:  John C Quinn; Nadine N Johnson-Farley; JiYoung Yoon; Daniel S Cowen
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

8.  Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms.

Authors:  Samarjit Bhattacharyya; Sapna Puri; Ricardo Miledi; Mitradas M Panicker
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-18       Impact factor: 11.205

9.  M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.

Authors:  E A Pehek; H G McFarlane; K Maguschak; B Price; C P Pluto
Journal:  Brain Res       Date:  2001-01-05       Impact factor: 3.252

10.  Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.

Authors:  Murat Oz; Li Zhang; Alessandro Rotondo; Hui Sun; Marisela Morales
Journal:  Synapse       Date:  2003-12-15       Impact factor: 2.562

View more
  18 in total

1.  Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI.

Authors:  Christin Y Sander; Jacob M Hooker; Ciprian Catana; Bruce R Rosen; Joseph B Mandeville
Journal:  Neuropsychopharmacology       Date:  2015-09-21       Impact factor: 7.853

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 3.  5-HT2A blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review.

Authors:  Cynthia Kwan; Imane Frouni; Dominique Bédard; Stephen G Nuara; Jim C Gourdon; Adjia Hamadjida; Philippe Huot
Journal:  Exp Brain Res       Date:  2018-11-15       Impact factor: 1.972

4.  Ubiquitination-deubiquitination balance dictates ligand-stimulated PTHR sorting.

Authors:  Verónica Alonso; Clara E Magyar; Bin Wang; Alessandro Bisello; Peter A Friedman
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

Review 5.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

6.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

7.  Dopamine and serotonin modulate human GABAρ1 receptors expressed in Xenopus laevis oocytes.

Authors:  Lenin D Ochoa-de la Paz; Argel Estrada-Mondragón; Agenor Limón; Ricardo Miledi; Ataúlfo Martínez-Torres
Journal:  ACS Chem Neurosci       Date:  2011-12-09       Impact factor: 4.418

8.  Activation of D2-like dopamine receptors inhibits GABA and glycinergic neurotransmission to pre-motor cardiac vagal neurons in the nucleus ambiguus.

Authors:  J Dyavanapalli; P Byrne; D Mendelowitz
Journal:  Neuroscience       Date:  2013-05-29       Impact factor: 3.590

9.  Expression and Purification of Functionally Active Serotonin 5-HT2A Receptor in Insect Cells Using Low-titer Viral Stock.

Authors:  Sukanya Mozumder; Gopa Mahesh; Krishnamoorthi Srinivasan; Jayati Sengupta; Sujoy Mukherjee
Journal:  Bio Protoc       Date:  2020-08-05

10.  Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.

Authors:  Stephanie M Matt; Emily A Nickoloff-Bybel; Yi Rong; Kaitlyn Runner; Hannah Johnson; Margaret H O'Connor; Elias K Haddad; Peter J Gaskill
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.